Cue Biopharma's total assets for Q3 2025 were $31.64M, a decrease of -22.26% from the previous quarter. CUE total liabilities were $18.40M for the fiscal quarter, a -18.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.